Northleaf Capital Partners, a Toronto, Canada-based global private markets investment firm, closed Northleaf Growth Fund, its first direct growth equity fund, at US$212M.
This closing expands global private equity and venture capital/growth equity program, which has raised more than US$13 Billion to date. The program currently serves more than 140 institutional and family office investors across North America, the UK/EMEA and Asia.
NGF provides investors with access to a diversified portfolio of direct investments in companies across the technology and healthcare sectors, leveraging its partnerships with fund managers. The Fund’s strategy targets growth-stage companies in North America through a combination of direct co-investments and opportunistic secondary transactions, which have been key contributors to Northleaf’s established growth equity track record.
Northleaf Capital Partners is a global private markets investment firm with more than US$24 Billion in private equity and venture capital/growth equity, private credit and infrastructure commitments raised to date from public, corporate and multi-employer pension plans, endowments, foundations, financial institutions and family offices. Its 250-person team is located in Toronto, Chicago, London, Los Angeles, Melbourne, Menlo Park, Montreal, New York and Tokyo.
Over the past 15 years, Northleaf has supported companies such as BlueCat Networks, eSentire, Verafin and Zymeworks.